Bridging the gaps between real-world evidence and randomized controlled trials through transparency: an interview with Richard White, Oxford PharmaGenesis
Richard White (Oxford PharmaGenesis)
Register with The Evidence Base for free to access this content
By registering with The Evidence Base, you will receive our weekly round-up and other relevant editorial content. You can opt-out at any time. View our privacy policy here.